This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Anticoagulants Industry

corresponding Graph/Chart) II-83

 

Table 18: World 15-Year Perspective for Unfractionated Heparin

by Geographic Region/ Country - Percentage Breakdown of Dollar

Sales for US, Japan, Europe, and Rest of World Markets for

Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-84

 

Table 19: World Recent Past, Current & Future Analysis for Low

Molecular Weight Heparin by Geographic Region/Country - US,

Japan, Europe, and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-85

 

Table 20: World Historic Review for Low Molecular Weight

Heparin by Geographic Region/Country - US, Japan, Europe, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-86

 

Table 21: World 15-Year Perspective for Low Molecular Weight

Heparin by Geographic Region/Country - Percentage Breakdown of

Dollar Sales for US, Japan, Europe, and Rest of World Markets

for Years 2004, 2011 & 2018 (includes corresponding

Graph/Chart) II-87

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Atrial Fibrillation - A Key Risk Factor III-1

Price Controls III-1

US Anticoagulants Market III-2

FDA Approved Anticoagulants III-2

Table 22: Novel Drugs/Drug Candidates in the US

Anticoagulants Market III-3

Table 23: US Vitamin K Antagonists Market (2011):

Percentage Breakdown of Value Sales by Drug- Coumadin,

Warfarin Generics and Others (includes corresponding

Graph/Chart) III-3

 

Table 24: US Direct Thrombin (II) Inhibitors Market (2011):

Percentage Breakdown of Value Sales by Drug - Pradaxa,

Angiomax, Argatroban, Refludan and Others (includes

corresponding Graph/Chart) III-3

 

Table 25: US Market for Xarelto (2011): Percentage Share

Breakdown of Sales by Indication- Atrial Fibrillation and

8 of 15

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,012.35 -18.79 -0.11%
S&P 500 1,979.91 -4.22 -0.21%
NASDAQ 4,500.9220 -17.98 -0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs